Add this topic to your myFT Digest for news straight to your inbox
Research shows mRNA vaccines from Pfizer and Moderna are by far most effective third doses
WHO says differing predictions from Oxford, BioNTech and Moderna are ‘premature’
Stéphane Bancel foresees ‘material drop’ in current jabs’ effectiveness, sending stocks and oil prices lower
Combating coronavirus could end up resembling a game of whack-a-mole
Patent dispute is rare breakdown between biotech and agency that worked closely in recent years
Democratic senator calls Pfizer and Moderna to do more to address ‘unacceptable disparities’
US biotech’s shares fall as it points to delays in international shipping and manufacturing glitches for downgrade
People at high risk of catching coronavirus can now receive any of three vaccines authorised by US health agency
Stable funding for work on less glamorous diseases would make the system fairer and more resilient
Bullish projections show mRNA jab producers could generate more than $90bn in sales next year
Panel recommends third jabs for vulnerable people in step towards expanding US rollout of extra doses
Personalised cancer treatments are among those being developed using a technology once distrusted by big pharma
Announcement comes while industry fends off claims it has resisted efforts to expand jabs access
Analysts predict revenues from Covid-19 jabs will fall precipitously by 2024
Data come as US regulator weighs approval for booster shot to bolster immunity
Several pharma groups are hoping the Covid vaccine race will turn out to be a marathon, not a sprint
Pair who left agency two weeks ago among authors of scathing critique in academic journal
Concerns raised that vaccine sites and freight services will struggle during rollout of third jabs
Studies suggest stronger immune response than its mRNA rival and it wanes more slowly
Men in their 30s with no underlying health conditions died three days after second shot
Drugmaker still thinks booster shots will be required later this year as Delta variant spreads
Calls for booster shots and spread of more infectious variants underpin demand for products
State department unveils plan to boost global supplies by spurring creation of overseas factories
Latecomers hope size, price or novel technology mean they can still play an important role in the pandemic
International Edition